Henry N. Wagner Jr., M.D.
Johns Hopkins School of Medicine
A pioneer in nuclear medicine and past president
of the Society of Nuclear Medicine, Henry N. Wagner
Jr., MD, has spent nearly five decades helping to
define and promote the specialty. His groundbreaking
work in the applications of nuclear medicine to
pulmonary and coronary artery disease and his
studies of brain chemistry with radiolabeled tracers
have led to significant advances in these fields.
Dr. Wagner is the director of the Division of
Radiation Health Sciences at Johns Hopkins
University in Baltimore, where he has worked since
1958. He is a professor emeritus of radiology and
radiological sciences at the Johns Hopkins School of
Medicine and a professor of environmental health
sciences at the School of Hygiene and Public Health.
While attending Johns Hopkins University, Dr. Wagner
completed his bachelor's degree, medical degree,
internship and residency. In 1955, he accepted a
clinical associate position with the National
Institutes of Health (NIH). After participating in a
special fellowship in London, he returned to Johns
Hopkins as an instructor and chief medical resident
of the Osler Medical Service.
Dr. Wagner's contributions to nuclear medicine have
brought him numerous honors and awards, and he has
three honorary degrees. In 1972, Dr. Wagner was the
recipient of the First Vikram Surhabel Gold Medal
from the Society of Nuclear Medicine of India, and
in 1993 he received the First Annual Society of
Nuclear Medicine President's Award for outstanding
contributions to nuclear medicine.
An internationally renowned expert in nuclear
medicine, Dr. Wagner serves as a consultant and
advisor to a number of scientiic, policy and
legislatie bodies. He is an advisory expert for the
Network of World Health Organization Collaborating
Centres and a member of the NIH Ad Hoc Advisory
Board on PET. He is also a member of the U.S. Food
and Drug Administration's Panel for Radiology
Devices and the Institute of Medicine. Dr. Wagner is
a consultant in nuclear medicine to Walter Reed Army
Medical Center in Washington, DC, and a national
consultant in nuclear medicine to the Surgeon
General of the United States.
A prolific researcher and writer, Dr. Wagner is
author or co-author of more than 800 publications,
including peer-reviewed journal articles, books and
chapters. He is a member of several editorial boards
and many medical and radiological societies, and an
honorary member of the British Institute of
Radiology (2000).
David J. Yang, PhD.
The University of Texas M. D. Anderson
Cancer Center
David J. Yang, Ph.D., is a Professor in the
Department of Experimental Nuclear Medicine and the
Director of Pharmaceutical Development at The
University of Texas M.D. Anderson Cancer Center in
Houston, TX. In addition, Dr. Yang has a dual
appointment as an Associate Professor with The
University of Houston School of Pharmacy and The
University of Texas Graduate School of Biomedical
Sciences. Prior to this position, Dr. Yang was
Assistant Professor and Assistant Chemist of Nuclear
Medicine at M.D. Anderson. Dr. Yang has spearheaded
research in developing new radiopharmaceuticals for
cancer diagnosis, monitoring, and therapy. He is a
world-recognized expert in radiopharmacology. Dr.
Yang has extensively published in the area of
radiopharmaceutical imaging and therapy. He has
published more than 75 articles and books, holds 34
patents and has presented at more than 100
conferences worldwide. An essential part of Dr.
Yang's current R&D effort is in the development of
new functional radiological contrast materials and
internal radiotherapeutics for NuclearMedicine. Dr.
Yang holds a Ph.D. from Northeast Louisiana
University in Medicinal Chemistry and a B.S. from
Taipei Medical College in Pharmacy.
Tony Yu, M.D.
The University of Texas M. D. Anderson Cancer Center
Tony Yu, M.D., is a Research Associate in the
Department of Nuclear Medicine at The University of
Texas M.D. Anderson Cancer Center in Houston, T.X..
Dr. Yu has worked and co-developed chemotherapy
agents and radiopharmaceuticals with Dr. Yang. Dr.
Yu has published more than 45 articles and holds 12
patents. He received his medical degree from the
University of China.
Saad Zakko, M.D.
Department of Nuclear Medicine, Dubai
Hospital
Dr. Saad Zakko has been the Director of Nuclear
Medicine at Dubai Hospital since 1986. Present
positions for Dr. Zakko include IAEA expert
(International Atomic Energy Agency), Vienna, Senior
Lecturer, Dubai Medical College, Member of the
Editorial Board, World Journal of Nuclear Medicine,
Member of the International Counsil, American
Society of Nuclear Cardiology and Adjunct Faculty
Member, College of Health Sciences, Sharjah
University. Dr. Zakko received his M.B.ChB from
Baghdad Medical College and MSc. Nuclear Medicine
from St. Thomas Hospital London, U.K. In February
2005, Dr. Zakko was the receipient of the Specialist
Achievement Award for Imaging presented by Arab
Health Awards 2005.